Genetic alterations in uterine fibroids – a new direction for pharmacological intervention?

Bibliography

• Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012;206:211.e1-9
   PubMed Web of Science ®Google Scholar
• Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci USA 2008;105:19887-92
   PubMed Web of Science ®Google Scholar
• Laser J, Lee P, Wei J-J. Cellular senescence in usual type uterine leiomyoma. Fertil Steril 2010;93:2020-6
   PubMed Web of Science ®Google Scholar
• Donnez J, Tomaszewski J, Vázquez F, et al. Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids. N Engl J Med 2012;366:421-32
   PubMed Web of Science ®Google Scholar
• D’Aloisio AA, Baird DD, DeRoo LA, et al. Association of Intrauterine and Early-Life Exposures with Diagnosis of Uterine Leiomyomata by 35 Years of Age in the Sister Study. Environ Health Perspect 2009;118:375-81
   Web of Science ®Google Scholar
• Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010;28:204-17
   PubMed Web of Science ®Google Scholar
• Bullerdiek J. Leiomyoma–do viruses play the main role? Genes Chromosomes Cancer 1999;26:181
   PubMed Web of Science ®Google Scholar
• Mehine M, Heinonen H-R, Sarvilinna N, et al. Clonally related uterine leiomyomas are common and display branched tumor evolution. Hum Mol Genet 2015;24(15):4407-16
   PubMed Web of Science ®Google Scholar
• Mashal RD, Fejzo ML, Friedman AJ, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 1994;11:1-6
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Azuma C, Kamiura S, et al. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 1995;40:204-8
   PubMed Web of Science ®Google Scholar
• Canevari RA, Pontes A, Rosa FE, et al. Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis. Am J Obstet Gynecol 2005;193:1395-403
   PubMed Web of Science ®Google Scholar
• Holdsworth-Carson SJ, Zaitseva M, Vollenhoven BJ, et al. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol Hum Reprod 2014;20:250-9
   PubMed Web of Science ®Google Scholar
• Nilbert M, Heim S, Mandahl N, et al. Karyotypic rearrangements in 20 uterine leiomyomas. Cytogenet Cell Genet 1988;49:300-4
   PubMedGoogle Scholar
• Heim S, Nilbert M, Vanni R, et al. A specific translocation, t(12;14)(q14-15;q23-24), characterizes a subgroup of uterine leiomyomas. Cancer Genet Cytogenet 1988;32:13-17
   PubMed Web of Science ®Google Scholar
• Gibas Z, Griffin CA, Emanuel BS. Clonal chromosome rearrangements in a uterine myoma. Cancer Genet Cytogenet 1988;32:19-24
   PubMed Web of Science ®Google Scholar
• Turc-Carel C, Dal Cin P, Boghosian L, et al. Consistent breakpoints in region 14q22-q24 in uterine leiomyoma. Cancer Genet Cytogenet 1988;32:25-31
   PubMed Web of Science ®Google Scholar
• Vanni R, Lecca U. Involvement of the long arm of chromosome 12 in chromosome rearrangements of uterine leiomyoma. Cancer Genet Cytogenet 1988;32:33-4
   PubMed Web of Science ®Google Scholar
• Mehine M, Kaasinen E, Mäkinen N, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 2013;369:43-53
   PubMed Web of Science ®Google Scholar
• Schoenmakers EF, Geurts JM, Kools PF, et al. A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Genomics 1995;29:665-78
   PubMed Web of Science ®Google Scholar
• Schoenmakers EF, Wanschura S, Mols R, et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 1995;10:436-44
   PubMed Web of Science ®Google Scholar
• Fejzo MS, Ashar HR, Krauter KS, et al. Translocation breakpoints upstream of theHMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosom. Cancer 1996;17:1-6
   Web of Science ®Google Scholar
• Schoenmakers EF, Huysmans C, Van de Ven WJ. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 1999;59:19-23
   PubMed Web of Science ®Google Scholar
• Gross KL, Neskey DM, Manchanda N, et al. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 2003;38:68-79
   PubMed Web of Science ®Google Scholar
• Klemke M, Meyer A, Nezhad MH, et al. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease. Genes Chromosomes Cancer 2009;48:171-8
   PubMed Web of Science ®Google Scholar
• Rogalla P, Drechsler K, Frey G, et al. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996;149:775-9
   PubMed Web of Science ®Google Scholar
• Zhou X, Benson KF, Przybysz K, et al. Genomic structure and expression of the murine Hmgi-c gene. Nucleic Acids Res 1996;24:4071-7
   PubMed Web of Science ®Google Scholar
• Markowski DN, Winter N, Meyer F, et al. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis. Genes Chromosomes Cancer 2011;50:489-98
   PubMed Web of Science ®Google Scholar
• Schwanbeck R, Manfioletti G, Wiśniewski JR. Architecture of high mobility group protein I-C.DNA complex and its perturbation upon phosphorylation by Cdc2 kinase. J Biol Chem 2000;275:1793-801
   PubMed Web of Science ®Google Scholar
• Reeves R. Structure and function of the HMGI(Y) family of architectural transcription factors. Environ Health Perspect 2000;108(Suppl):803-9
   PubMed Web of Science ®Google Scholar
• Cattaruzzi G, Altamura S, Tessari MA, et al. The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and function. Nucleic Acids Res 2007;35:1751-60
   PubMed Web of Science ®Google Scholar
• Cui T, Leng F. Specific recognition of AT-rich DNA sequences by the mammalian high mobility group protein AT-hook 2: a SELEX study. Biochemistry 2007;46:13059-66
   PubMed Web of Science ®Google Scholar
• Winter N, Nimzyk R, Bösche C, et al. Chromatin immunoprecipitation to analyze DNA binding sites of HMGA2. PLoS One 2011;6:e18837
   PubMed Web of Science ®Google Scholar
• Klemke M, Müller MH, Wosniok W, et al. Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models. PLoS One 2014;9:e88126
   PubMed Web of Science ®Google Scholar
• Li AYJ, Boo LM, Wang S-Y, et al. Suppression of Nonhomologous End Joining Repair by Overexpression of HMGA2. Cancer Res 2009;69:5699-706
   PubMed Web of Science ®Google Scholar
• Bullerdiek J, Rommel B. Comment re: HMGA2 is a negative regulator of DNA-PK pathway. Cancer Res 2010;70:1742
   PubMed Web of Science ®Google Scholar
• Kazmierczak B, Bol S, Wanschura S, et al. PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes Chromosomes Cancer 1996;17:191-3
   PubMed Web of Science ®Google Scholar
• Nezhad MH, Drieschner N, Helms S, et al. 6p21 rearrangements in uterine leiomyomas targeting HMGA1. Cancer Genet Cytogenet 2010;203:247-52
   PubMed Web of Science ®Google Scholar
• Schoenmakers EF, Bunt J, Hermers L, et al. Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes Chromosomes Cancer 2013;52:11-23
   PubMed Web of Science ®Google Scholar
• Vanharanta S, Wortham NC, Langford C, et al. Definition of a minimal region of deletion of chromosome 7 in uterine leiomyomas by tiling-path microarray CGH and mutation analysis of known genes in this region. Genes Chromosomes Cancer 2007;46:451-8
   PubMed Web of Science ®Google Scholar
• Ozisik YY, Meloni AM, Surti U, et al. Involvement of 10q22 in leiomyoma. Cancer Genet Cytogenet 1993;69:132-5
   PubMed Web of Science ®Google Scholar
• Moore SDP, Herrick SR, Ince TA, et al. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res 2004;64:5570-7
   PubMed Web of Science ®Google Scholar
• Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. Cancer Genet Cytogenet 2005;158:1-26
   PubMed Web of Science ®Google Scholar
• Rein MS, Powell WL, Walters FC, et al. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 1998;4:83-6
   PubMed Web of Science ®Google Scholar
• Hennig Y, Deichert U, Bonk U, et al. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol Hum Reprod 1999;5:1150-4
   PubMed Web of Science ®Google Scholar
• Mäkinen N, Mehine M, Tolvanen J, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 2011;334:252-5
   PubMed Web of Science ®Google Scholar
• Di Tommaso S, Massari S, Malvasi A, et al. Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy. Expert Opin Ther Targets 2015;19:7-12
   PubMed Web of Science ®Google Scholar
• Markowski DN, Nimzyk R, Belge G, et al. Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non-B DNA structures and hypermutability. Mol Cytogenet 2013;6:23
   PubMed Web of Science ®Google Scholar
• Markowski DN, Tadayyon M, Bartnitzke S, et al. Cell cultures in uterine leiomyomas: Rapid disappearance of cells carrying MED12 mutations. Genes Chromosom Cancer 2014;53:317-23
   PubMed Web of Science ®Google Scholar
• Mäkinen N, Heinonen H-R, Moore S, et al. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget 2011;2:966-9
   PubMedGoogle Scholar
• Markowski DN, Bartnitzke S, Löning T, et al. MED12 mutations in uterine fibroids - their relationship to cytogenetic subgroups. Int J Cancer 2012;131:1528-36
   PubMed Web of Science ®Google Scholar
• McGuire MM, Yatsenko A, Hoffner L, et al. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS ONE 2012;7:e33251
   PubMed Web of Science ®Google Scholar
• Je EM, Kim MR, Min KO, et al. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer 2012;131:E1044-7
   PubMed Web of Science ®Google Scholar
• Mehine M, Kaasinen E, Mäkinen N, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 2013;369:43-53
   PubMed Web of Science ®Google Scholar
• Tomlinson IPM, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-10
   PubMed Web of Science ®Google Scholar
• Alam NA, Rowan AJ, Wortham NC, et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003;12:1241-52
   PubMed Web of Science ®Google Scholar
• Garman ME, Blumberg MA, Ernst R, et al. Familial leiomyomatosis: a review and discussion of pathogenesis. Dermatology 2003;207:210-13
   PubMed Web of Science ®Google Scholar
• Gross KL, Panhuysen CIM, Kleinman MS, et al. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer 2004;41:183-90
   PubMed Web of Science ®Google Scholar
• Lehtonen R, Kiuru M, Vanharanta S, et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 2004;164:17-22
   PubMed Web of Science ®Google Scholar
• Heidet L, Dahan K, Zhou J, et al. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum Mol Genet 1995;4:99-108
   PubMed Web of Science ®Google Scholar
• Heidet L, Cohen-Solal L, Boye E, et al. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region. Cytogenet Cell Genet 1997;78:240-6
   PubMedGoogle Scholar
• Rieker RJ, Agaimy A, Moskalev EA, et al. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata). Pathology 2013;45:388-92
   PubMed Web of Science ®Google Scholar
• Lim WK, Ong CK, Tan J, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet 2014;46:877-80
   PubMed Web of Science ®Google Scholar
• Pfarr N, Kriegsmann M, Sinn P, et al. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast-implications for tumor biology and pathological diagnosis. Genes Chromosomes Cancer 2015;54(7):444-52
   PubMed Web of Science ®Google Scholar
• Nagasawa S, Maeda I, Fukuda T, et al. MED12 exon 2 mutations in phyllodes tumors of the breast. Cancer Med 2015;4(7):1117-21
   Google Scholar
• Staats B, Bonk U, Wanschura S, et al. A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 1996;38:299-303
   PubMed Web of Science ®Google Scholar
• Bartuma H, Hallor KH, Panagopoulos I, et al. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer 2007;46:594-606
   PubMed Web of Science ®Google Scholar
• Bol S, Wanschura S, Thode B, et al. An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 1996;90:88-90
   PubMed Web of Science ®Google Scholar
• Kazmierczak B, Wanschura S, Rommel B, et al. Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings. J Natl Cancer Inst 1996;88:1234-6
   PubMed Web of Science ®Google Scholar
• Geurts JM, Schoenmakers EF, Röijer E, et al. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res 1997;57:13-17
   PubMed Web of Science ®Google Scholar
• Persson F, Andrén Y, Winnes M, et al. High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2. Genes Chromosomes Cancer 2009;48:69-82
   PubMed Web of Science ®Google Scholar
• Rohen C, Rogalla P, Meyer-Bolte K, et al. Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements. Cancer Genet Cytogenet 1999;111:178-81
   PubMed Web of Science ®Google Scholar
• Fletcher JA, Longtine J, Wallace K, et al. Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: evidence for a pathogenetic relationship with lipomas and leiomyomas. Genes Chromosomes Cancer 1995;12:220-3
   PubMed Web of Science ®Google Scholar
• Wanschura S, Kazmierczak B, Pohnke Y, et al. Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality. Cancer Lett 1996;102:17-21
   PubMed Web of Science ®Google Scholar
• Hess JL. Chromosomal translocations in benign tumors: the HMGI proteins. Am J Clin Pathol 1998;109:251-61
   PubMed Web of Science ®Google Scholar
• Tallini G, Vanni R, Manfioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 2000;80:359-69
   PubMed Web of Science ®Google Scholar
• Nyquist KB, Panagopoulos I, Thorsen J, et al. t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia. Br J Haematol 2012;157:769-71
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 2010;467:318-22
   PubMed Web of Science ®Google Scholar
• Kiechle-Schwarz M, Berger CS, Surti U, et al. Rearrangement of band 10q22 in leiomyoma and leiomyosarcoma of the uterus. Cancer Genet Cytogenet 1990;47:95-100
   PubMed Web of Science ®Google Scholar
• Sreekantaiah C, Davis JR, Sandberg AA. Chromosomal abnormalities in leiomyosarcomas. Am J Pathol 1993;142:293-305
   PubMed Web of Science ®Google Scholar
• Panagopoulos I, Fioretos T, Isaksson M, et al. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet 2001;10:395-404
   PubMed Web of Science ®Google Scholar
• Zaidi MR, Okada Y, Chada KK. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. Cancer Res 2006;66:7453-9
   PubMed Web of Science ®Google Scholar
• Pedeutour F, Quade BJ, Sornberger K, et al. Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14. Genes Chromosomes Cancer 2000;27:209-15
   PubMed Web of Science ®Google Scholar
• Markowski DN, Helmke BM, Bartnitzke S, et al. Uterine Fibroids: Do We Deal With More Than One Disease? Int J Gynecol Pathol 2014;33:568-72
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366:409-20
   PubMed Web of Science ®Google Scholar
• Markowski DN, Helmke BM, Radtke A, et al. Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium. BMC Womens Health 2012;12:2
   PubMedGoogle Scholar